Taguma Y - Search Results

1

A femoral vein catheter with immobilized urokinase (UKFC) as an antithrombotic blood access.

Kitamoto Y, Fukui H, Iwabuchi K, Taguma Y, Monma H, Ishizaki M, Takahashi H, Nakayama M, Sekino H. Kitamoto Y, et al. Among authors: taguma y. ASAIO Trans. 1987 Jul-Sep;33(3):136-9. ASAIO Trans. 1987. PMID: 3675935 No abstract available.

2

Urinary thrombin: a novel marker of glomerular inflammation for the diagnosis of crescentic glomerulonephritis (prospective observational study).

Kitamoto Y, Arizono K, Fukui H, Tomita K, Kitamura H, Taguma Y, Imamura T. Kitamoto Y, et al. Among authors: taguma y. PLoS One. 2015 Mar 5;10(3):e0118704. doi: 10.1371/journal.pone.0118704. eCollection 2015. PLoS One. 2015. PMID: 25742509 Free PMC article.

3

Effect of captopril on heavy proteinuria in azotemic diabetics.

Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y. Taguma Y, et al. N Engl J Med. 1985 Dec 26;313(26):1617-20. doi: 10.1056/NEJM198512263132601. N Engl J Med. 1985. PMID: 3906398

4

Liposarcoma of the renal capsule.

Sasagawa I, Suzuki K, Ishizaki M, Takahashi H, Taguma Y, Nakamura K, Suzuki K. Sasagawa I, et al. Among authors: taguma y. Urol Int. 1992;48(2):223-5. doi: 10.1159/000282338. Urol Int. 1992. PMID: 1585521 Review.

5

Suboptimal initiation predicts short-term prognosis and vulnerability among very elderly patients who start haemodialysis.

Kanno A, Nakayama M, Sanada S, Sato M, Sato T, Taguma Y. Kanno A, et al. Among authors: taguma y. Nephrology (Carlton). 2019 Jan;24(1):94-101. doi: 10.1111/nep.13194. Nephrology (Carlton). 2019. PMID: 29131496

6

Mode of progression of secondary hyperparathyroidism in patients with chronic renal failure.

Matsubara M, Sugai H, Taguma Y, Ishizaki M, Suzuki K, Takahashi H, Saito T, Yoshinaga K. Matsubara M, et al. Among authors: taguma y. Nephron. 1991;58(1):122-3. doi: 10.1159/000186396. Nephron. 1991. PMID: 1857473 Free article. No abstract available.

7

Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.

Matsubara M, Taguma Y, Kurosawa K, Hotta O, Suzuki K, Ishizaki M. Matsubara M, et al. Among authors: taguma y. J Lab Clin Med. 1990 Aug;116(2):206-10. J Lab Clin Med. 1990. PMID: 2394938

8

Urinary Thrombin as a Marker of Glomerular Inflammation Associated with Renal Injury in Type 2 Diabetes.

Kitamoto Y, Imamura T, Taguma Y, Iwaoka T, Yorinaka H, Arizono K. Kitamoto Y, et al. Among authors: taguma y. Tohoku J Exp Med. 2021 Jan;253(1):41-49. doi: 10.1620/tjem.253.41. Tohoku J Exp Med. 2021. PMID: 33441513 Free article.

9

[Oral high dose 1,25(OH)2D3 pulse therapy].

Matsubara M, Sugai H, Taguma Y, Suzuki K, Ishizaki M, Takahashi H. Matsubara M, et al. Among authors: taguma y. Nihon Jinzo Gakkai Shi. 1991 Feb;33(2):119-23. Nihon Jinzo Gakkai Shi. 1991. PMID: 2051637 Japanese.

10

Usefulness of dialysate fibrin degradation products and lactic dehydrogenase isoenzyme patterns in assessing the clinical course of peritonitis.

Suzuki K, Ishizaki M, Hotta O, Horigome I, Sudo K, Kurosawa K, Taguma Y. Suzuki K, et al. Among authors: taguma y. Perit Dial Int. 1994;14(3):231-5. Perit Dial Int. 1994. PMID: 7948233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters